Metabolic Side Effects and Cardiovascular Events of Diuretics: Should a Diuretic Remain the First Choice Therapy in Hypertension Treatment? The Case of Yes

Author： Papadopoulos Dimitris   Papademetriou Vasilios  

Publisher： Informa Healthcare

ISSN： 1064-1963

Source： Clinical and Experimental Hypertension, Vol.29, Iss.8, 2007-11, pp. : 503-516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lessons from ALLHAT: Are low budget diuretics first line therapy in hypertension?

By Unger T.  

Zeitschrift für Kardiologie, Vol. 93, Iss. 5, 2004-05 ,pp. : 349-356

Springer Publishing Company

Access to resources Recommend Favorite

Should torsemide be the loop diuretic of choice in systolic heart failure?

By DiNicolantonio James J  

Future Cardiology, Vol. 8, Iss. 5, 2012-09 ,pp. : 707-728

Future Medicine

Access to resources Recommend Favorite

Are Calcium Channel Blockers First-Line Drugs for the Treatment of Hypertension and Cardiovascular Disease?

By  

Current Hypertension Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 9-13

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2

By Ekbom Tord   Linjer Erland   Hedner Thomas   Lanke Jan   de Faire Ulf   Wester P.-O.   Dahlöf Björn   Scherstén Bengt  

Blood Pressure, Vol. 13, Iss. 3, 2004-06 ,pp. : 137-141

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular and Metabolic Effects of Ghrelin

By  

Current Diabetes Reviews, Vol. 6, Iss. 4, 2010-07 ,pp. : 228-235

Bentham Science Publishers

Access to resources Recommend Favorite